1. Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation
   SiJin Li et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
2. Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity?
   Nicola Normanno et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef
3. Metamorphic Effect of Angiogenic Switch in Tumor Development: Conundrum of Tumor Angiogenesis Toward Progression and Metastatic Potential
   Daniel Leon Moshe et al, 2023, Biomedicines CrossRef
4. Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids
   Xintong Cai et al, 2024, Frontiers in Oncology CrossRef
5. The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies
   Ombretta Melaiu et al, 2023, International Journal of Molecular Sciences CrossRef
6. Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
   T. Al-Toubah et al, 2024, ESMO Open CrossRef
7. PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC)
   A. Cavazzoni et al, 2024, Lung Cancer CrossRef
8. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
   Katarzyna Starska-Kowarska, 2023, Cancers CrossRef
9. Differential expression of angiogenesis-related genes ‘VEGF’ and ‘angiopoietin-1’ in metastatic and EMAST-positive colorectal cancer patients
   Amir Torshizi Esfahani et al, 2024, Scientific Reports CrossRef
10. Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?
    Manon Teisseire et al, 2024, Biomedicines CrossRef
11. The Potential Influence of Residual or Recurrent Disease on Bevacizumab Treatment Efficacy in Ovarian Cancer: Current Evidence and Future Perspectives
    Klaudia Żak et al, 2024, Cancers CrossRef
12. Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors
    Yan Kang et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
13. Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation
    Michael Li et al, 2024, Journal of Hepatology CrossRef
14. Prognostic Role of Vascular Endothelial Growth Factor and Correlation with Oxidative Stress Markers in Locally Advanced and Metastatic Ovarian Cancer Patients
    Oana Gabriela Trifanescu et al, 2023, Diagnostics CrossRef
15. Improving the efficiency of immune checkpoint inhibitors for metastatic pMMR/MSS colorectal cancer: Options and strategies
    Changjiang Yang et al, 2024, Critical Reviews in Oncology/Hematology CrossRef